- beta-(Diethylamino)ethyl p-aminobenzoate
- beta-Diethylaminoethyl 4-aminobenzoate
- Diethylaminoethyl p-aminobenzoate
- 2-(Diethylamino)ethyl p-aminobenzoate
- 2-Diethylaminoethyl 4-aminobenzoate
Anhydrous plates, tables from ligroin or ether.
Registry Numbers and Inventories.
Drug; Human Data
Japan ENCS (MITI)
Melting point, °C
332.5 - 334
Boiling point, °C
228 - 231 (6 torr)
Solubility in water
9.45 g/L @ 30 C
Partition coefficient, pKow
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stable in air.
Strong oxidizing agents.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Generalized depression of vital signs may follow a period of transient physiological stimulation. CNS effects invariably precede significant cardiovascular toxicity, except following massive iv injection.
Nausea, vomiting, and depression of the gag reflex may occur.
Apnea and respiratory depression may occur in patients with coma or seizures. Increased respirations are associated with milder forms of CNS stimulation. ARDS has been reported in patients with aspiration or during hypersensitivity reactions.
Urticaria and angioedema may accompany systemic allergic reactions. Other dermatological effects include contact dermatitis, generalized burning and numbness, and pruritus. Vasodilation, with pink skin, has been reported.
Constriction of the pupil and tinnitus may occur.
Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.